Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
15.645
Zitationen
19
Autoren
1993
Jahr
Abstract
These results support the EORTC QLQ-C30 as a reliable and valid measure of the quality of life of cancer patients in multicultural clinical research settings. Work is ongoing to examine the performance of the questionnaire among more heterogenous patient samples and in phase II and phase III clinical trials.
Ähnliche Arbeiten
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 · 7.291 Zit.
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
1993 · 5.951 Zit.
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
2010 · 4.935 Zit.
Cancer treatment and survivorship statistics, 2019
2019 · 4.371 Zit.
Cancer treatment and survivorship statistics, 2022
2022 · 3.640 Zit.
Autoren
Institutionen
- The Netherlands Cancer Institute(NL)
- Zimmer Biomet (Germany)(DE)
- European Organisation for Research and Treatment of Cancer(BE)
- Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
- University of Cologne(DE)
- Long Island Jewish Medical Center(US)
- University of Amsterdam(NL)
- Academic Medical Center(NL)
- Norwegian Cancer Society(NO)
- Rigshospitalet(DK)
- BC Cancer Agency(CA)
- Institut Jules Bordet(BE)
- Royal Adelaide Hospital(AU)
- Centre Hospitalier Universitaire de Besançon(FR)
- Sahlgrenska University Hospital(SE)
- Saitama Cancer Center(JP)